Lea Rahtu‐Korpela

HIF Prolyl 4-Hydroxylase-2 Inhibition Improves Glucose and Lipid Metabolism and Protects Against Obesity and Metabolic Dysfunction

Lea Rahtu‐Korpela, Sara Karsikas, Sohvi Hörkkö et al. · Diabetes · 2014 · 116 citations

Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis

Lea Rahtu‐Korpela, Jenni Määttä, Elitsa Y. Dimova et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2016 · 88 citations · Full text

Systemic Blockade of ACVR2B Ligands Protects Myocardium from Acute Ischemia-Reperfusion Injury

Johanna Magga, Laura Vainio, Teemu Kilpiö et al. · Molecular Therapy · 2019 · 33 citations · Full text

miR-1468-3p Promotes Aging-Related Cardiac Fibrosis

Ruizhu Lin, Lea Rahtu‐Korpela, Johanna Magga et al. · Molecular Therapy — Nucleic Acids · 2020 · 29 citations · Full text

MiR-185-5p regulates the development of myocardial fibrosis

Ruizhu Lin, Lea Rahtu‐Korpela, Zoltán Szabó et al. · Journal of Molecular and Cellular Cardiology · 2021 · 26 citations · Full text